# FDA Inspection 1159513 - Daniel Fred Goodman, M.D. - December 13, 2021

Source: https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/936fa295-a792-48b3-9102-1b99c535babc
Source feed: FDA_Inspections

> FDA Inspection 1159513 for Daniel Fred Goodman, M.D. on December 13, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1159513
- Company Name: Daniel Fred Goodman, M.D.
- Inspection Date: 2021-12-13
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255006 - 2024-11-25](https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/2ed39930-450c-4176-b906-735fc2e3c0c9)
- [FDA Inspection 1255006 - 2024-11-25](https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/77de55b0-f05c-4852-807a-a1a240dbb107)

Company: https://www.keypedia.com/companies/daniel-fred-goodman-md/75721ae4-0e50-488f-bbb5-22b050bc0249

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c